INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 455m ago
HOUSE PTR54m ago
SEC 13F54m ago
ROBINHOOD CHAIN54m ago
Corporate insider
KW

Kolbeck Roland Wilhelm

Chief Scientific OfficerCIK 0002076327

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score15
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
KW
Kolbeck Roland WilhelmChief Scientific Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
95.7K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Aclaris Therapeutics, Inc.Chief Scientific Officer · Feb 6, 2026
15
KW
Kolbeck Roland WilhelmChief Scientific Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A
—
334.9K sh
Feb 2, 2026
Feb 6, 2026
traded Feb 2, 2026
+4d
SEC FORM 4

Evidence